214 related articles for article (PubMed ID: 24429170)
1. Time to recovery from proteinuria in patients with lupus nephritis receiving standard treatment.
Touma Z; Urowitz MB; Ibañez D; Gladman DD
J Rheumatol; 2014 Apr; 41(4):688-97. PubMed ID: 24429170
[TBL] [Abstract][Full Text] [Related]
2. Remission of proteinuria indicates good prognosis in patients with diffuse proliferative lupus nephritis.
Koo HS; Kim S; Chin HJ
Lupus; 2016 Jan; 25(1):3-11. PubMed ID: 26159540
[TBL] [Abstract][Full Text] [Related]
3. Collapsing glomerulopathy in 19 patients with systemic lupus erythematosus or lupus-like disease.
Salvatore SP; Barisoni LM; Herzenberg AM; Chander PN; Nickeleit V; Seshan SV
Clin J Am Soc Nephrol; 2012 Jun; 7(6):914-25. PubMed ID: 22461531
[TBL] [Abstract][Full Text] [Related]
4. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; de Ramon Garrido E; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
Arthritis Rheum; 2004 Dec; 50(12):3934-40. PubMed ID: 15593207
[TBL] [Abstract][Full Text] [Related]
5. Response to combination of mycophenolate mofetil, cyclosporin A and corticosteroid treatment in lupus nephritis patients with persistent proteinuria.
Kasitanon N; Boripatkosol P; Louthrenoo W
Int J Rheum Dis; 2018 Jan; 21(1):200-207. PubMed ID: 28901731
[TBL] [Abstract][Full Text] [Related]
6. Effect of complete or partial proteinuria recovery on long-term outcomes of lupus nephritis.
Medina-Rosas J; Fung WA; Su J; Touma Z
Semin Arthritis Rheum; 2018 Feb; 47(4):557-564. PubMed ID: 28888363
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome in Japanese patients with lupus nephritis.
Kono M; Yasuda S; Kato M; Kanetsuka Y; Kurita T; Fujieda Y; Otomo K; Horita T; Oba K; Kondo M; Mukai M; Yanai M; Fukasawa Y; Atsumi T
Lupus; 2014 Oct; 23(11):1124-32. PubMed ID: 24860121
[TBL] [Abstract][Full Text] [Related]
8. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of cyclosporine A in patients with refractory systemic lupus erythematosus in a daily clinical practice.
Ogawa H; Kameda H; Amano K; Takeuchi T
Lupus; 2010 Feb; 19(2):162-9. PubMed ID: 19952069
[TBL] [Abstract][Full Text] [Related]
10. Clinical predictors of proteinuric remission following an LN flare - evidence from the UK JSLE cohort study.
Smith EMD; Yin P; Jorgensen AL; Beresford MW;
Pediatr Rheumatol Online J; 2018 Feb; 16(1):14. PubMed ID: 29467038
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis.
Arends S; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M; Berden JH;
Ann Rheum Dis; 2012 Jun; 71(6):966-73. PubMed ID: 22128082
[TBL] [Abstract][Full Text] [Related]
12. Prognosis of proliferative lupus nephritis subsets in the Louvain Lupus Nephritis inception Cohort.
Vandepapelière J; Aydin S; Cosyns JP; Depresseux G; Jadoul M; Houssiau FA
Lupus; 2014 Feb; 23(2):159-65. PubMed ID: 24300780
[TBL] [Abstract][Full Text] [Related]
13. The dynamics of urinary N-acetyl-β-D-glucosaminidase (NAG), a marker of renal tubular dysfunction, in patients with lupus nephritis undergoing oral prednisone therapy.
Gluhovschi C; Velciov S; Kaycsa A; Gluhovschi G; Petrica L; Marian R; Bozdog G; Gadalean F; Bob F; Cioca D; Vernic C
Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):163-9. PubMed ID: 21651460
[TBL] [Abstract][Full Text] [Related]
14. Delayed lupus nephritis in the course of systemic lupus erythematosus is associated with a poorer treatment response: a multicentre, retrospective cohort study in Japan.
Nakano M; Kubo K; Shirota Y; Iwasaki Y; Takahashi Y; Igari T; Inaba Y; Takeshima Y; Tateishi S; Yamashita H; Miyazaki M; Sato H; Kanda H; Kaneko H; Ishii T; Fujio K; Tanaka N; Mimori A
Lupus; 2019 Aug; 28(9):1062-1073. PubMed ID: 31296139
[TBL] [Abstract][Full Text] [Related]
15. Effect of low-dose cyclosporine A in the treatment of refractory proteinuria in childhood-onset lupus nephritis.
Baca V; Catalán T; Villasís-Keever M; Ramón G; Morales AM; Rodríguez-Leyva F
Lupus; 2006; 15(8):490-5. PubMed ID: 16942000
[TBL] [Abstract][Full Text] [Related]
16. Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methylprednisolone.
Cortés-Hernández J; Ordi-Ros J; Labrador M; Segarra A; Tovar JL; Balada E; Vilardell-Tarres M
Lupus; 2003; 12(4):287-96. PubMed ID: 12729052
[TBL] [Abstract][Full Text] [Related]
17. Renal outcome in patients with lupus nephritis using a steroid-free regimen of monthly intravenous cyclophosphamide: a prospective observational study.
Fischer-Betz R; Chehab G; Sander O; Vordenbäumen S; Voiculescu A; Brinks R; Schneider M
J Rheumatol; 2012 Nov; 39(11):2111-7. PubMed ID: 22984276
[TBL] [Abstract][Full Text] [Related]
18. Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE.
Dooley MA; Houssiau F; Aranow C; D'Cruz DP; Askanase A; Roth DA; Zhong ZJ; Cooper S; Freimuth WW; Ginzler EM;
Lupus; 2013 Jan; 22(1):63-72. PubMed ID: 23263865
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up in lupus nephritis patients treated with rituximab--clinical and histopathological response.
Jónsdóttir T; Zickert A; Sundelin B; Henriksson EW; van Vollenhoven RF; Gunnarsson I
Rheumatology (Oxford); 2013 May; 52(5):847-55. PubMed ID: 23287364
[TBL] [Abstract][Full Text] [Related]
20. Low-dose tacrolimus in treating lupus nephritis refractory to cyclophosphamide: a prospective cohort study.
Fei Y; Wu Q; Zhang W; Chen H; Hou Y; Xu D; Li M; Zhang X; Zhao Y; Zeng X; Zhang F
Clin Exp Rheumatol; 2013; 31(1):62-8. PubMed ID: 22935463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]